- Home
- GCTK vs CHEK Comparison
GCTK vs CHEK Comparison
Compare GCTK & CHEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GCTK
- CHEK
- Stock Information
- Founded
- GCTK 2001
- CHEK 2004
- Country
- GCTK United States
- CHEK Israel
- Employees
- GCTK N/A
- CHEK N/A
- Industry
- GCTK Medical/Dental Instruments
- CHEK Medical Electronics
- Sector
- GCTK Health Care
- CHEK Health Care
- Exchange
- GCTK Nasdaq
- CHEK Nasdaq
- Market Cap
- GCTK 3.3M
- CHEK 3.9M
- IPO Year
- GCTK N/A
- CHEK 2015
- Fundamental
- Price
- GCTK $7.15
- CHEK $2.20
- Analyst Decision
- GCTK
- CHEK
- Analyst Count
- GCTK 0
- CHEK 0
- Target Price
- GCTK N/A
- CHEK N/A
- AVG Volume (30 Days)
- GCTK 3.7M
- CHEK 8.5M
- Earning Date
- GCTK 11-13-2025
- CHEK 11-14-2025
- Dividend Yield
- GCTK N/A
- CHEK N/A
- EPS Growth
- GCTK N/A
- CHEK N/A
- EPS
- GCTK N/A
- CHEK N/A
- Revenue
- GCTK N/A
- CHEK N/A
- Revenue This Year
- GCTK N/A
- CHEK N/A
- Revenue Next Year
- GCTK N/A
- CHEK N/A
- P/E Ratio
- GCTK N/A
- CHEK N/A
- Revenue Growth
- GCTK N/A
- CHEK N/A
- 52 Week Low
- GCTK $4.22
- CHEK $0.56
- 52 Week High
- GCTK $2,928.00
- CHEK $3.13
- Technical
- Relative Strength Index (RSI)
- GCTK 56.95
- CHEK 58.54
- Support Level
- GCTK $6.18
- CHEK $2.12
- Resistance Level
- GCTK $6.66
- CHEK $2.40
- Average True Range (ATR)
- GCTK 0.59
- CHEK 0.28
- MACD
- GCTK 0.06
- CHEK -0.04
- Stochastic Oscillator
- GCTK 58.80
- CHEK 10.94
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.